Genome-wide expression profiling of RNA interference of hepatitis B virus gene expression and replication

Cell Mol Life Sci. 2004 Aug;61(16):2113-24. doi: 10.1007/s00018-004-4111-2.

Abstract

Small interfering RNA (siRNA) has been used repeatedly to down-regulate viral gene expression and inhibit viral replication in mammalian cells. In this study, we showed that siRNAs specific for two conserved regions within the hepatitis B S antigen (HBsAg) gene can inhibit antigen production in two human liver cell lines which constitutively produce and secrete HBsAg. The inhibitory effect was concentration dependent for both PLC/PRF/5 and 2.2.15 cells. Decreases in the corresponding viral transcript levels were observed. The inhibitory effect was observed within 24 h and was still evident 7 days after the initial treatment with siRNA. A significant reduction in virion production was also observed for the 2.2.15 cells. A critical consideration in this study was the specificity of the siRNA-mediated inhibition. To address this, we first examined the effects on cell growth and viability. These were not affected in either cell line. cDNA microarrays were also used to examine genome-wide changes in gene regulation. No significant off-target gene regulation was observed in either cell line. Our findings thus indicate that siRNA can specifically mediate the down-regulation of viral gene expression leading to a reduction in virion production.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Gene Expression Profiling
  • Gene Expression Regulation, Viral / physiology*
  • Hepatitis B virus / genetics*
  • Hepatitis B virus / physiology
  • Humans
  • Oligonucleotide Array Sequence Analysis
  • RNA Interference / physiology*
  • RNA, Small Interfering / physiology
  • Transfection
  • Virus Replication / physiology*

Substances

  • RNA, Small Interfering